Yatırımcı.AI

USUSDOct 30, 03:00

Gilead Sciences Inc

Gilead Sciences Inc GILD

USD 170.685.07 (3.06%)

About TRY 8,528.91 · converted at USD/TRY 49.9702, November 2, 2026, 18:40

Previous close
165.61
Market cap
USD 211.7B

Key Data

USD 211.7B
USD −3.13
Previous close
165.61
Avg. volume (200d)
6.8M
Sector
Healthcare
Industry
Drug Manufacturers - General

Technical Signals

Technical signals

Only our Plus members can access this area.

AI Models

AI models

Only our Plus members can access this area.

About Gilead Sciences Inc

Gilead Sciences Inc (GILD) last traded at 170.68 USD on the US stock market, a daily move of 3.06%. Converted at the USD/TRY rate of 49.9702 as of November 2, 2026, 18:40, this price equals about TRY 8,528.91; the conversion is for information only and the rate a broker applies may differ. Market capitalization is 211.7B USD, earnings per share −3.13 USD, the price-to-earnings ratio — and the dividend yield 1.96%. The company operates in the Healthcare sector, within the Drug Manufacturers - General industry.

Frequently Asked Questions

Gilead Sciences Inc (GILD) last traded at 170.68 USD, a daily change of 3.06%. Prices are delayed by at least 15 minutes.

The last price of Gilead Sciences Inc (GILD) is USD 170.68. Converted at the USD/TRY rate of 49.9702 as of November 2, 2026, 18:40, that is about TRY 8,528.91. The conversion is for information only; trades use the exchange rate and fees your broker applies.

US stocks such as Gilead Sciences Inc (GILD) can be bought through Turkish brokerage firms (aracı kurumlar) that offer access to foreign markets. You open an account enabled for foreign equity trading; because US stocks trade in dollars, the account and trades are in USD, so lira savings are converted to dollars first. The regular session on the NYSE and Nasdaq runs from 09:30 to 16:00 New York time, which is 16:30–23:00 Türkiye time while US daylight saving time is in effect and 17:30–00:00 otherwise. Taxation is subject to Turkish tax law; check the Revenue Administration (GİB) for current rules.

GILD trades at a price-to-earnings ratio of —, with earnings per share of −3.13 USD and a market capitalization of 211.7B USD. Ratios use the latest reported results and the current price.

The 52-week range for GILD cannot be calculated right now.

The current dividend yield of GILD is 1.96%. Dividend yield is the annual cash dividend divided by the share price; the company may change its policy.

Gilead Sciences Inc (GILD) is listed on the US stock market; its sector is Healthcare and its industry is Drug Manufacturers - General.

Prices, volume and fundamentals come from licensed data providers; prices are delayed by at least 15 minutes and fundamentals refresh daily. AI forecasts are generated by Yatırımcı.AI models and are not investment advice.